Search Results - "Nagarajarao, Harsha"

Refine Results
  1. 1
  2. 2

    Cajal Cell Counts are Important Predictors of Outcomes in Drug Refractory Gastroparesis Patients With Neurostimulation by Omer, Endashaw, Kedar, Archana, Nagarajarao, Harsha S, Nikitina, Yana, Vedanarayanan, Vetta, Subramony, Charu, Lahr, Christopher J, Abell, Thomas L

    Published in Journal of clinical gastroenterology (01-05-2019)
    “…BACKGROUND AND AIMS:Cajal cells serve as the pacemaker cells of the gastrointestinal tract and regulates peristalsis. On the baisis of that fact, it has been…”
    Get full text
    Journal Article
  3. 3

    The Clinical Significance of Physiological Assessment of Residual Ischemia After Percutaneous Coronary Intervention by Ojha, Chandra P., Ibrahim, Ahmed, Paul, Timir K., Mulukutla, Venkatachalam, Nagarajarao, Harsha S.

    Published in Current cardiology reports (08-02-2020)
    “…Purpose of Review Fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) have emerged as the invasive diagnostic tools of choice for hemodynamic…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Serum Catecholamines and Dysautonomia in Diabetic Gastroparesis and Liver Cirrhosis by Aslam, Naeem, MD, Kedar, Archana, MD, Nagarajarao, Harsha S., MD, Reddy, Kartika, MD, Rashed, Hani, MD, Cutts, Teresa, PhD, Abell, Thomas L., MD, Riely, Caroline, MD

    “…Background Plasma catecholamine influences autonomic function and control, but there are few reports correlating them. In this study, 47 individuals (mean age,…”
    Get full text
    Journal Article
  6. 6

    Current Use and Trends in Unprotected Left Main Coronary Artery Percutaneous Intervention by Nagarajarao, Harsha S., Ojha, Chandra P., Mulukutla, Venkatachalam, Ibrahim, Ahmed, Mares, Adriana C., Paul, Timir K.

    Published in Current cardiology reports (08-02-2020)
    “…Purpose of Review To review the clinical evidence on the use of percutaneous coronary intervention (PCI) revascularization options in left main (LM) disease in…”
    Get full text
    Journal Article
  7. 7

    Medical Therapy Versus Revascularization in Patients with Stable Ischemic Heart Disease and Advanced Chronic Kidney Disease by Paul, Timir K., Mamas, Mamas A., Shanmugasundaram, Madhan, Nagarajarao, Harsha S., Ojha, Chandra P., Jneid, Hani, Kumar, Gautam, White, Christopher J.

    Published in Current cardiology reports (01-04-2021)
    “…Purpose of Review This article reviews the evidence on optimal medical therapy (OMT) versus coronary revascularization in patients with stable ischemic heart…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The Predictive Value of Left Atrial Size for Incident Ischemic Stroke and All-Cause Mortality in African Americans : The Atherosclerosis Risk in Communities (ARIC) Study by NAGARAJARAO, Harsha S, PENMAN, Alan D, TAYLOR, Herman A, MOSLEY, Thomas H, BUTLER, Kenneth, SKELTON, Thomas N, SAMDARSHI, Tandaw E, ARU, Giorgio, FOX, Ervin R

    Published in Stroke (1970) (01-10-2008)
    “…The association between left atrial (LA) size, ischemic stroke, and death has not been well established in African Americans despite their disproportionately…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    The relation of C--reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study by Fox, Ervin R, Benjamin, Emelia J, Sarpong, Daniel F, Nagarajarao, Harsha, Taylor, Jason K, Steffes, Michael W, Salahudeen, Abdullah K, Flessner, Michael F, Akylbekova, Ermeg L, Fox, Caroline S, Garrison, Robert J, Taylor, Jr, Herman A

    Published in BMC nephrology (15-01-2010)
    “…African Americans have an increased incidence and worse prognosis with chronic kidney disease (CKD--estimated glomerular filtration rate [eGFR] <60 ml/min/1.73…”
    Get full text
    Journal Article
  15. 15
  16. 16

    C-reactive protein and subclinical cardiovascular disease among African−Americans: (the Jackson Heart Study) by Sung, Jung Hye, Lee, Jae Eun, Samdarshi, Tandaw E, Nagarajarao, Harsha S, Taylor, Jason K, Agrawal, Khushboo K, Taylor, Herman A, Fox, Ervin R

    “…OBJECTIVESystemic inflammation has been implicated as an early marker for subclinical cardiovascular disease; however, findings have been inconsistent in the…”
    Get full text
    Journal Article
  17. 17

    Unusual Presentation of Chronic Myelogenous Leukemia as Multiple Skin Chloromas : Report of a Case with Clinical and Cytologic Correlation by SANTHESHIVARA NAGARAJARAO, Harsha, AKHTAR, Israh, HEARD, Ken, BALIGA, Mithra

    Published in Acta cytologica (01-03-2009)
    “…Chronic myelogenous leukemia (CML) presenting as multiple skin chloromas is an extremely rare manifestation. Though often seen in acute myelogenous leukemia,…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20